___

• 1. Karimpour A, Esmaeelnezhad Moghadam A, Moslemizadeh N, et al. Incidence and main causes of infertility in patients attending the infertility center of Imam Khomeini Hospital in 2002-2004. J Mazandaran Univ Med Sci 2005;15:44-9.
• 2. Kazem M, Ali A. An overview of the epidemiology of primary infertility in Iran. J Reprod Infertility 2009;10:213-16.
• 3. Jaiswar SP, Sachan R, Singh RK, et al. Free radicals in female infertility. J Obstet Gynecol India 2006;56:64-7.
• 4. Kumari P, Jaiswar SP, Shankhwar P, et al. Leptin as a predictive marker in unexplained infertility in north indian population. J Clin Diagn Res 2017;11:QC28-31.
• 5. Te Velde ER, Eijkemans R, Habbema HD. Variation in couple fecundity and time to pregnancy, an essential concept in human reproduction. Lancet 2000;355:1928-29.
• 6. Collin JA, Rowe TC. Age study of the female partner is aprognostic factor in prolonged unexplained infertility: A multicentre study. Fertil Steril 1989;52:15-20.
• 7. Tola EN. The association between in vitro fertilization outcome and the inflammatory markers of complete blood count among nonobese unexplained infertile couples. Taiwan J Obstet Gynecol 2018;57:289-94.
• 8. Blacker CM, Ginsburg KA, Leach RE, et al. Unexplained infertility: evaluation of the luteal phase; results of the National Center for Infertility Research at Michigan. Fertil Steril 1997;67:437-42.
• 9. Guzick DS, Carson SA, Coutifaris C, et al. Efficacy of super ovulation and intrauterine insemination in the treatment of infertility, National Cooperative Reproductive Medicine Network. N Engl J Med 1999;340:177-83.
• 10. Leach RE, Moghissi KS, Randolph JF, et al. Intensive hormone monitoring in women with unexplained infertility: evidence for subtle abnormalities suggestive of diminished ovarian reserve. Fertil Steril 1997;68:413-20.
• 11. Vitek WS, Galarraga O, Klatsky PC, et al. . Management of the first in vitro fertilization cycle for unexplained infertility: a costeffectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection. Fertil Steril 2013;100:1381-8.
• 12. Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 2011;335:30-41.
• 13. Turan V, Sezer ED, Zeybek B, et al. Sendag F. Infertility and the presence of insülin resistance are associated with increased oxidative stress in young, non-obese Turkish women with polycystic ovary syndrome. J Pediatr Adolesc Gynecol 2015;28:11-23.
• 14. Hyderali BN, Mala K. Oxidative stress and cardiovascular complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2015;191:15-22.
• 15. Orio Jr F, Palomba S, Cascella T, et al. The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:2-5.
• 16. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137-61.
• 17. An LF, Zhang XH, Sun XT, et al. Unexplained infertility patients have increased serum IL-2, IL-4, IL-6, IL-8, IL-21,
• TNFalpha, IFNgamma and increased Tfh/CD4 T cell ratio: increased Tfh and IL-21 strongly correlate with presence of autoantibodies. Immunol Invest 2015;44:164-73.
• 18. Practice Committee of the American Society for Reproductive Medicine. Effectiveness and treatment for unexplained infertility. Fertilsteril 2006;86:111.
• 19. Vitek WS, Galarraga O, Klatsky PC, et al. Management of the first in vitro fertilization cycle for unexplained infertility: a costeffectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection. Fertil Steril 2013;100:1381-8.
• 20. Spritzer PM, Lecke SB, Satler F, et al. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction 2015;149:219-27
• 21. Hoffman M, Blum A, Baruch R, et al. Leukocytes and coronary heart disease. Atherosclerosis 2004;172:1-6
• 22. Silfeler DB, Kurt RK, Yengil E, et al. Evaluation of Mean Platelet Volume values in lean women with polycystic ovary syndrome. Pak J Med Sci 2014;30:589-92
• 23. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137e61.24.
• 24. Verit FF, Cetin O, Yildirim O, et al. Neutrophil to lymphocyte ratio is superior to platelet to lymphocyte ratio as an early predictor of moderate/severe ovarian hyperstimulation syndrome. J Obstet Gynaecol 2014;34:639-43.
• 25. Fornari MC, Sarto A, Berardi VE, et al. Effect of ovaric hyper-stimulation on blood lymphocyte subpopulations, cytokines,leptin and nitrite among patients with unexplained infertility. Am J Reprod Immunol 2002;48:394-403.
• 26. Işikci T, Hassa H, Aydin Y, Açıklanamayan infertilite olgularında ivf başarısı predikte edilebilir mi?. Turkiye Klinikleri J Gynecol Obstet 2014;24:104-9.
• 27. Cakiroglu Y, Vural F, Vural B. The inflammatory markers in polycystic ovary syndrome: association with obesity and IVF outcomes. J Endocrinol Invest 2016;39:899-907.
• 28. An LF, Zhang XH, Sun XT, et al. Unexplained infertilitypatients have increased serum IL-2, IL-4, IL-6, IL-8, IL-21, TNFalpha, IFNgamma and increased Tfh/CD4 T cell ratio: increased Tfh and IL-21 strongly correlate with presence of autoantibodies. Immunol Invest 2015;44:164-73.
• 29. Gasparyan AY, Ayvazyan L, Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011;17:47-58.
• 30. Jasper MJ, Tremellen KP, Robertson SA. Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod 2006;12:301-8.
• 31. Balta S, Celik T, Mikhailidis DP, et al. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost 2016;22:405-11.